- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT04717648
C-Reactive Protein and Sodium in Predicting Anastomotic Leakage
The Effect of Postoperative C-Reactive Protein and Sodium Value on the Early Prediction of Anastomotic Leaks in Patients Operated on for Colorectal Cancer
Anastomotic leakage is serious morbidity that can develop in patients operated on for colorectal cancer and can reach potentially life-threatening dimensions. Many international studies have been conducted to reduce and eliminate this postoperative complication that may have a mortal course. In these studies, preoperative, perioperative and postoperative factors of the patient, operation techniques, structure of the material used in the operation and multiple factors belonging to the surgeon were held responsible. Intraabdominal sepsis secondary to late anastomotic leakage and subsequent multiorgan failure can cost the patient's life. Anastomotic leaks that develop in patients who have been operated for colorectal cancer; In order to detect patients' postoperative clinical findings, laboratory examinations, imaging tests, and to eliminate them before intraabdominal sepsis develops, studies including many different laboratory and imaging methods have been carried out. Although previous studies have shown that there are many laboratory examinations and imaging methods that can predict anastomotic leaks early, they have many advantages over each other in terms of efficiency, sensitivity, specificity, and cost.
The investigators aimed to investigate the effectiveness of C reactive protein and blood sodium value, as well as their superiority, among the tests that can predict postoperative anastomotic leakage, especially in patients who have undergone a single anastomosis following resection for non-metastatic colorectal cancer.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
- Investigate the effectiveness of postoperative C-reactive protein and sodium values in predicting anastomotic leakage in the early postoperative period in patients who have undergone anastomosis following resection for non-metastatic colorectal cancer, and their superiority to each other.
- Investigate the effectiveness of these laboratory parameters in developing anastomotic leaks according to tumor location and different age subgroups (<45 years, 45-65 years,> 65 years).
Tipo de estudo
Inscrição (Real)
Contactos e Locais
Locais de estudo
-
-
-
İzmir, Peru, 35180
- Tepecik Training and Research Hospital
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Método de amostragem
População do estudo
Descrição
Inclusion Criteria:
- Patients over the age of 18 who were operated due to elective colorectal cancer
- Patients who are known to have no solid organ metastases in preoperative imaging methods and whose perioperative surgery notes support this finding
- Patients with ileocolic, colocolic, colorectal anastomosis during the operation
- Patients whose postoperative 1,3,5th day C- Reactive protein and sodium values were measured
Exclusion Criteria:
- Patients under the age of 18
- Emergency operated patients
- Patients on a routine dialysis program due to Chronic renal failure
- Patients with a known diagnosis of liver cirrhosis
- Patients who are irresectable during the operation and therefore have undergone palliative surgery
- Patients whose C- Reactive protein and Sodium values were not measured on the postoperative 1, 3, 5th day
- Patients with abdominoperineal resection and no bowel anastomosis during the operation
- Patients who have not undergone ileocolic, colocolic, colorectal or ileorectal anastomosis during the operation.
- Patients found to be metastatic during the operation
- Patients who have undergone additional surgical resection (metastasectomy, etc.) due to solid organ metastasis during the operation
- Patients who have had more than one gastrointestinal anastomosis during the same surgery
- Patients undergoing concurrent hyperthermic intraperitoneal chemotherapy (HIPEC) and / or cytoreductive surgery
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
Coortes e Intervenções
Grupo / Coorte |
Intervenção / Tratamento |
|---|---|
|
Patients with anastomotic leakage
Post operative anastomotic leakage
|
C Reactive protein and sodium
|
|
Patients without anastomotic leakage
Post operative without anastomotic leakage
|
C Reactive protein and sodium
|
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Early predictive factors of anastomotic leakege
Prazo: 2 or 3 days
|
The anastomotic leak of the measurement The measurement tool is the laboratory parameters.
|
2 or 3 days
|
Colaboradores e Investigadores
Patrocinador
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Termos MeSH relevantes adicionais
- Doenças do aparelho digestivo
- Processos Patológicos
- Neoplasias
- Neoplasias por local
- Complicações pós-operatórias
- Neoplasias gastrointestinais
- Neoplasias do Aparelho Digestivo
- Doenças Gastrointestinais
- Doenças do cólon
- Doenças Intestinais
- Neoplasias Intestinais
- Doenças retais
- Neoplasias Colorretais
- Vazamento Anastomótico
Outros números de identificação do estudo
- 2020/13-51
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .